Damora Therapeutics, Inc. (DMRA)
NASDAQ: DMRA · Real-Time Price · USD
28.96
-0.48 (-1.63%)
Jul 28, 2026, 1:53 PM EDT - Market open
Damora Therapeutics Market Cap
Damora Therapeutics has a market cap or net worth of $1.78 billion as of July 28, 2026. Its market cap has increased by 35,847.49% in one year.
Market Cap
1.78B
Enterprise Value
1.28B
1-Year Change
35,847.49%
Ranking
Category
Stock Price
$28.96
ChartMarket Cap Chart
Since October 29, 2020, Damora Therapeutics's market cap has increased from $368.78M to $1.78B, an increase of 383.37%. That is a compound annual growth rate of 31.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 1.78B | 4,749.98% |
| Dec 31, 2025 | 36.75M | 500.17% |
| Dec 31, 2024 | 6.12M | -68.63% |
| Dec 29, 2023 | 19.52M | -33.64% |
| Dec 30, 2022 | 29.42M | -61.57% |
| Dec 31, 2021 | 76.54M | -75.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kardigan | 1.85B |
| Fortrea Holdings | 1.85B |
| Syndax Pharmaceuticals | 1.84B |
| Lakefront Biotherapeutics NV | 1.84B |
| Stoke Therapeutics | 1.82B |
| Tyra Biosciences | 1.82B |
| Immunocore Holdings | 1.78B |
| Bicara Therapeutics | 1.78B |